Opportunity to benefit over 2 million patients annually
The Eximis Surgical platform has the potential for use in multiple minimally invasive procedures, including hysterectomies which are performed over a million times annually.
A $2 billion market potential
With the huge number of procedures performed and the clinical value that Eximis Surgical may provide, the untapped market of minimally invasive specimen removal can grow to be $2B over the next five years.
2.2M Worldwide Annual Procedures